Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?

被引:16
|
作者
Anwar, Sirajudheen [1 ,2 ,3 ]
Malik, Jonaid Ahmad [4 ,5 ]
Ahmed, Sakeel [6 ]
Kameshwar, Verma Abhishek [7 ]
Alanazi, Jowaher [1 ,2 ,3 ]
Alamri, Abdulwahab [1 ,2 ,3 ]
Ahemad, Nafees [8 ]
机构
[1] Univ Hail, Coll Pharm, Dept Pharmacol & Toxicol, Hail 81422, Saudi Arabia
[2] Univ Hail, Mol Diagnost Unit, Hail 81422, Saudi Arabia
[3] Univ Hail, Personalized Treatment, Hail 81422, Saudi Arabia
[4] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Gauhati 781101, Assam, India
[5] Indian Inst Technol Ropar, Dept Biomed Engn, Rupnagar 140001, Punjab, India
[6] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Ahmadabad 382355, Gujarat, India
[7] Amrita Vishwa Vidyapeetham, Dept Pharmacol, Amrita Sch Pharm, Kochi 641112, Kerala, India
[8] Monash Univ Malaysia, Sch Pharm, Jalan Lagoon Selatan, Petaling Jaya 47500, Selangor De, Malaysia
来源
MOLECULES | 2022年 / 27卷 / 22期
关键词
epithelial-mesenchymal transition; cancer EMT; natural chemical entities; cancer; anticancer therapy; chemotherapy; EPITHELIAL-MESENCHYMAL TRANSITION; SPONGE CHONDROSIA-CORTICATA; GROWTH-FACTOR-BETA; NF-KAPPA-B; BREAST-CANCER; DOXORUBICIN RESISTANCE; MULTIDRUG-RESISTANCE; LUTEOLIN SUPPRESSES; DRUG-RESISTANCE; DOWN-REGULATION;
D O I
10.3390/molecules27227668
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is the leading cause of death and has remained a big challenge for the scientific community. Because of the growing concerns, new therapeutic regimens are highly demanded to decrease the global burden. Despite advancements in chemotherapy, drug resistance is still a major hurdle to successful treatment. The primary challenge should be identifying and developing appropriate therapeutics for cancer patients to improve their survival. Multiple pathways are dysregulated in cancers, including disturbance in cellular metabolism, cell cycle, apoptosis, or epigenetic alterations. Over the last two decades, natural products have been a major research interest due to their therapeutic potential in various ailments. Natural compounds seem to be an alternative option for cancer management. Natural substances derived from plants and marine sources have been shown to have anti-cancer activity in preclinical settings. They might be proved as a sword to kill cancerous cells. The present review attempted to consolidate the available information on natural compounds derived from plants and marine sources and their anti-cancer potential underlying EMT mechanisms.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Natural Products as Anticancer Agents
    Varghese, Ruby
    Dalvi, Yogesh B.
    CURRENT DRUG TARGETS, 2021, 22 (11) : 1272 - 1287
  • [22] Anticancer Properties of Natural Products
    Zupko, Istvan
    Jaeger, Walter
    Topcu, Zeki
    Wu, Chin-Chung
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [23] Anticancer Potential of Azole Containing Marine Natural Products: Current and Future Perspectives
    Rani, Dimpy
    Garg, Vandana
    Dutt, Rohit
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (15) : 1957 - 1976
  • [24] Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
    Ko, Joshua K.
    Auyeung, Kathy K.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (21) : 2346 - 2356
  • [25] The recent update and advancements of natural products in targeting the Wnt/β-Catenin pathway for cancer prevention and therapeutics
    Saikia, Lunasmrita
    Gogoi, Bhaskarjyoti
    Sen, Saikat
    Tonk, Rajiv K.
    Kumar, Deepak
    Dutta, Partha Pratim
    MEDICAL ONCOLOGY, 2024, 41 (07)
  • [26] Targeting BDNF signaling by natural products: Novel synaptic repair therapeutics for neurodegeneration and behavior disorders
    Bawari, Sweta
    Tewari, Devesh
    Arguelles, Sandro
    Sah, Archana N.
    Nabavi, Seyed Fazel
    Xu, Suowen
    Vacca, Rosa Anna
    Nabavi, Seyed Mohammad
    Shirooie, Samira
    PHARMACOLOGICAL RESEARCH, 2019, 148
  • [27] Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics
    El-Far, Ali H.
    Al Jaouni, Soad K.
    Li, Xiaotao
    Fu, Junjiang
    PHYTOTHERAPY RESEARCH, 2022, 36 (08) : 3181 - 3201
  • [28] Recent advances in epigenetic anticancer therapeutics and future perspectives
    Ren, Liwen
    Yang, Yihui
    Li, Wan
    Yang, Hong
    Zhang, Yizhi
    Ge, Binbin
    Zhang, Sen
    Du, Guanhua
    Wang, Jinhua
    FRONTIERS IN GENETICS, 2023, 13
  • [29] Current paradigms in epigenetic anticancer therapeutics and future challenges
    Singh, Manoj
    Kumar, Vikas
    Sehrawat, Nirmala
    Yadav, Mukesh
    Chaudhary, Mayank
    Upadhyay, Sushil K.
    Kumar, Sunil
    Sharma, Varruchi
    Kumar, Sandeep
    Dilbaghi, Neeraj
    Sharma, Anil K.
    SEMINARS IN CANCER BIOLOGY, 2022, 83 : 422 - 440
  • [30] The role of artificial intelligence in the development of anticancer therapeutics from natural polyphenols: Current advances and future prospects
    Zheng, Ying
    Ma, Yifei
    Xiong, Qunli
    Zhu, Kai
    Weng, Ningna
    Zhu, Qing
    PHARMACOLOGICAL RESEARCH, 2024, 208